Assessment of safety and long-term outcomes of initial treatment with placebo in TADS. - Wikidata - awgldk - TriplyDB

Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.

Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.

http://www.wikidata.org/entity/Q33659631

about

Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents Trajectories of Functioning Into Emerging Adulthood Following Treatment for Adolescent Depression.Mental health service use among adolescents following participation in a randomized clinical trial for depression.Recovery and recurrence following treatment for adolescent major depression.Onset of alcohol or substance use disorders following treatment for adolescent depression.Relabeling the medications we call antidepressants.Placebo Response in Pediatric Anxiety Disorders: Implications for Clinical Trial Design and Interpretation.Adolescent suicide and SSRI antidepressants.

P2860

Q24197563-22D81344-6A2B-4E4F-A2D7-341040FFBD7F Q30353906-80A69142-1FCC-4119-986C-70CAE0FA5AD5 Q34245194-8335CCD3-130C-4736-AA35-ED01F72E420E Q34780705-0688C4DF-FB23-4EF5-B11C-22A42720F0C2 Q35856922-3AD9A10F-F2C4-4825-87FC-C2C17195FD8D Q37288504-43EF327B-BFB3-463E-A8CC-B2BE1223ED13 Q39878590-BF288D68-7756-491C-B146-A8386863FEEF Q42789935-462C65C5-A1DA-464F-ADBA-911FF71BCD6E

P2860

Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.

http://www.wikidata.org/entity/Q33659631

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.

@ast

Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.

@en

type

label

Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.

@ast

Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.

@en

prefLabel

Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.

@ast

Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.

@en

P1433

Q33659631-F8494889-285F-4E9E-85BD-9A26AE89EC6C

P1476

Q33659631-D17D511B-23B9-41EE-8996-E161D38D2F70

P2093

Q33659631-037F5FE1-4161-4D80-AE21-AF8505FA4908

Q33659631-039DC916-9DA6-4E2F-BF1D-857A23CEBD05

Q33659631-0D23672D-6913-4AD2-8D3B-6EF0B915F1E4

Q33659631-1037F3DD-84FA-4408-A237-B102761A6207

Q33659631-27978BAC-A556-4617-A55E-FEA2777B0FD5

Q33659631-52F15A0F-5EC8-4BE7-AD42-033214BBB003

Q33659631-5FF79EA4-E1F8-4B0B-AA2E-C652617A93B3

Q33659631-8F3AF78E-DF9C-4B92-AA22-2FA369B679EA

Q33659631-ABAB6C76-CAD6-41EF-9A20-64C21BE5D1C0

Q33659631-ACF20A77-CA2F-4AD1-A96D-66408148BF09

P2860

Q33659631-0B4533CE-EA31-4358-9CDA-B35BF8B155D6

Q33659631-176E1A1D-2EB1-424F-99B6-168840A4AB9E

Q33659631-1D83C004-3FF2-4A87-B602-1BD4F90258C3

Q33659631-32F970D7-0B83-4662-98EB-0ECFDA6D2F11

Q33659631-3DC777D4-2E65-4D98-8408-E1988B40E8D8

Q33659631-3DF25B77-2501-49F3-A035-7476281BB6BB

Q33659631-7FB3A54B-87D2-4B5F-BBE8-696E97457214

Q33659631-A9938945-A7E1-476D-BEF6-EA7685A4AE10

Q33659631-C5A4D6CB-AFD2-46C1-BBA8-AA1602B105E8

Q33659631-D1E6F592-8F6A-4586-A385-8B2CFAAC60F3

P304

Q33659631-B78A5151-BCED-47BC-8334-960711898E80

P31

Q33659631-C654C826-CE2E-4DD4-B99F-C0082EC7C302

P356

Q33659631-22C09982-D9DA-402B-A75A-8C01C12357CA

P407

Q33659631-8C4581D8-EE32-45E3-BD7A-C04AA44FCFBE

P433

Q33659631-2B666EC8-0C93-4F1D-8428-CAD5C4DF1DB3

P478

Q33659631-691DD827-EBE5-4F5D-81EE-B69220167854

P577

Q33659631-13A51597-22F7-4C80-A9B3-4641B09D008C

P5875

Q33659631-CC220F1D-C81E-49BF-BDFA-755E75579B77

P698

Q33659631-6F9C5C14-D5FE-437C-A64D-DEDA05C82F1A

P921

Q33659631-EEE2E920-8892-4692-B40D-ED1651C1015D

P932

Q33659631-9144B90B-5E8E-4521-8431-3B1A99B4B525

P356

APPI.AJP.2008.08040487

P1433

American Journal of Psychiatry

P1476

Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.

@en

P2093

Benedetto Vitiello

http://www.w3.org/2001/XMLSchema#string

Betsy D Kennard

http://www.w3.org/2001/XMLSchema#string

Christopher J Kratochvil

http://www.w3.org/2001/XMLSchema#string

Graham J Emslie

http://www.w3.org/2001/XMLSchema#string

Jennifer L Hughes

http://www.w3.org/2001/XMLSchema#string

John F Curry

http://www.w3.org/2001/XMLSchema#string

John S March

http://www.w3.org/2001/XMLSchema#string

Mark A Reinecke

http://www.w3.org/2001/XMLSchema#string

Paul Rohde

http://www.w3.org/2001/XMLSchema#string

Susan G Silva

http://www.w3.org/2001/XMLSchema#string

P2860

Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database.

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders.

Treatment for Adolescents with Depression Study (TADS): safety results

The ethical use of placebo in clinical trials involving children.

The Treatment for Adolescents With Depression Study (TADS): demographic and clinical characteristics.

Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy.

Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants.

A manual-based intervention to address clinical crises and retain patients in the Treatment of Adolescents With Depression Study (TADS).

Treatment for Adolescents With Depression Study (TADS): rationale, design, and methods.

P304

337-344

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1176/APPI.AJP.2008.08040487

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

166

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23791636

http://www.w3.org/2001/XMLSchema#string

P698

19147693

http://www.w3.org/2001/XMLSchema#string

P921

P932

2823118

http://www.w3.org/2001/XMLSchema#string